A NAD+ 1000mg & Retatrutide: A UK Innovation in Physiological Function
Emerging findings from the UK are generating considerable interest surrounding the potential combination of high-dose NAD+ supplementation (1000mg) and the novel GLP-1 receptor agonist, Retatrutide. This unique approach aims to target multiple facets of metabolic disorder, potentially offering a